The effect of reminiscence therapy

The effect of reminiscence therapy on cognitive disorders and depression in hemodialysis' patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201607186318N8

Enrollment

Registered

2016-08-06

Start date

2016-07-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive disorders and depression in hemodialysis' patients. Dementia in other specified diseases classified elsewhere

Interventions

Intervention 1: Intervention group 1, participates in 12 sessions Stinson reminiscence, attended nurse and psychotherapist, for 30 to 35 minutes, twice a week. Intervention 2: Intervention group 2, in

Behavior

Intervention group 1, participates in 12 sessions Stinson reminiscence, attended nurse and psychotherapist, for 30 to 35 minutes, twice a week.

Intervention group 2, in 12 sessions for 35 to 30 minutes and twice a week talking about everyday issues with the nurse and psychotherapist.

Control group, hemodialysis was done with previous process.

Eligibility

Sex/Gender

All

Age

25 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 25 to 75 years; ability to read; write; visual and verbal communication; lack of cognitive or chronic mental disorders; no deaths of a close family and friends in the last three months; lack of addiction to drugs abuse or alcohol; get MMSE questionnaire score 25-10. Exclusion criteria: having a history of suicidal thoughts; psychosis; mental retardation; vision and hearing problems; absence more than one session.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Cognitive status. Timepoint: Before, immediately after and one month after the intervention. Method of measurement: Variable measurement method: In this study, Cognitive status is measured by using MMSE questionnaire. Score of cognitive health (25-30), mild cognitive disorders (21-24), moderate (10-20) severe (<9). Information for each person will be recorded in a specific questionnaire for each patient.	—

Measure

Time frame

Cognitive status. Timepoint: Before, immediately after and one month after the intervention. Method of measurement: Variable measurement method: In this study, Cognitive status is measured by using MMSE questionnaire. Score of cognitive health (25-30), mild cognitive disorders (21-24), moderate (10-20) severe (<9). Information for each person will be recorded in a specific questionnaire for each patient.

—

Secondary

Measure	Time frame
Depression. Timepoint: Before, immediately after and one month after the intervention. Method of measurement: Depression is measured by using the Beck Depression Inventory. Beck Depression Inventory tests their polls. There are a total of 21 tests of four-point scale from zero to three to respond. Scores range from zero to 63. Score and severity of depression is divided to mild (11-16), moderate (17-29) and major (30-63). Information for each person will be recorded in a specific questionnaire for each patient.	—

Measure

Time frame

Depression. Timepoint: Before, immediately after and one month after the intervention. Method of measurement: Depression is measured by using the Beck Depression Inventory. Beck Depression Inventory tests their polls. There are a total of 21 tests of four-point scale from zero to three to respond. Scores range from zero to 63. Score and severity of depression is divided to mild (11-16), moderate (17-29) and major (30-63). Information for each person will be recorded in a specific questionnaire for each patient.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMonir Nobahar

Semnan University of Medical Sciences

nobahar43@semums.ac.ir+98 912 231 1345

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026